Transplantation, Kidney
16
0
0
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
2 terminated out of 16 trials
81.8%
-4.7% vs benchmark
13%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients
VEL-101 to Prevent Rejection After Kidney Transplantation
To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation
Special Access for the Use of Voclosporin for Kidney Transplantation
Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
Comparison of ATG to Thymoglobuline in Renal Transplantation
Transversus Abdominis Plane (TAP) Block After Kidney Transplantation
GFR Measurement With Contrast-enhanced Dynamic MRI
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
A Study to Evaluate FK778 in Kidney Transplant Patients
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group